Severe immune-related hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma

被引：0
|
作者：
Fetter, T. [1 ]
Fietz, S. [1 ]
De Vos, L. [1 ]
Bertlich, M. [1 ]
Bragelmann, C. [1 ]
Bieber, T. [1 ]
Wenzel, J. [1 ]
Heine, A. [2 ]
Landsberg, J. [1 ]
Jansen, P. [1 ]
机构：
[1] Univ Klinikum Bonn, Klin Dermatol & Allergol, Bonn, Germany
[2] Univ Klinikum Bonn, Medizin Klin Hamatol Onkol 3, Bonn, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP102
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [1] Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report
    Fetter, Tanja
    Fietz, Simon
    Bertlich, Maya
    Braegelmann, Christine
    de Vos-Hillebrand, Luka
    Wenzel, Joerg
    Heine, Annkristin
    Landsberg, Jennifer
    Jansen, Philipp
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
    Woelffer, Marcus
    Battke, Florian
    Schulze, Martin
    Feldhahn, Magdalena
    Flatz, Lukas
    Martus, Peter
    Forschner, Andrea
    CANCERS, 2022, 14 (02)
  • [3] Immune-related Bell's palsy in melanoma patients treated with immune checkpoint inhibitors
    Beninato, Teresa
    Fuca, Giovanni
    Di Guardo, Lorenza
    Vetrano, Irene
    Valeri, Barbara
    Nesa, Francesco
    Del Vecchio, Michele
    Cimminiello, Carolina
    MELANOMA RESEARCH, 2021, 31 (02) : 178 - 180
  • [4] Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors
    Finkel, Inbar
    Sternschuss, Michal
    Wollner, Mira
    Shamai, Sivan
    Peled, Nir
    Turgeman, Ilit
    Shochat, Tzippy
    Dudnik, Elizabeth
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (02) : 67 - 74
  • [5] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
    Gault, A.
    Anderson, A. E.
    Plummer, R.
    Stewart, C.
    Pratt, A. G.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 263 - 271
  • [6] Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series
    Tew, Alice
    Khoja, Leila
    Pallan, Lalit
    Steven, Neil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1163 - 1171
  • [7] IMMUNE-RELATED ADVERSE EVENTS FOLLOWING IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Zhu, Kaiwen
    Niu, Chengu
    Liu, Hongli
    Okolo, Patrick
    GASTROENTEROLOGY, 2023, 164 (06) : S1431 - S1432
  • [8] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [10] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
12345